A Phase 1 Clinical Trial of NPI-0052 in Patients With Advanced Malignancies.
Phase of Trial: Phase I
Latest Information Update: 27 Nov 2017
At a glance
- Drugs Marizomib (Primary)
- Indications Cancer; Leukaemia; Lymphoma; Multiple myeloma; Solid tumours
- Focus Adverse reactions
- Sponsors Nereus Pharmaceuticals; Triphase Accelerator Corporation
- 26 Apr 2016 Results published in the Clinical cancer research: an official journal of the American Association for Cancer Research
- 01 Apr 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 01 Feb 2013 Lead trial center changed as reported by ClinicalTrials.gov.